Evidence map›Paper›PMID 30384810›Full record

ArticleTechnology in cancer research & treatment2018

Nicotine Induces Progressive Properties of Lung Adenocarcinoma A549 Cells by Inhibiting Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Plasma Membrane Localization.

Hui Li, Ningxia Ma, Jing Wang, Ying Wang, Chao Yuan, Jing Wu, Meihui Luo, Jiali Yang, Juan Chen, Juan Shi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Ion Channels in Lung Cancer.Reviews of physiology, biochemistry and pharmacology · 2021
    Review
  8. Article
  9. Cystic Fibrosis, CFTR, and Colorectal Cancer.International journal of molecular sciences · 2020
    Review
  10. Review
  11. A Positive Feed Forward Loop between Wnt/Oxidative medicine and cellular longevity · 2020
    Article
  12. Role of ion channels in gastrointestinal cancer.World journal of gastroenterology · 2019
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hui Li1 College of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
Ningxia Ma1 College of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
Jing Wang3 Center of Laboratory Medicine, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China.
Ying Wang1 College of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
Chao Yuan4 College of Life Science, Ningxia University, Yinchuan, Ningxia, China.
Jing Wu1 College of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
Meihui Luo4 College of Life Science, Ningxia University, Yinchuan, Ningxia, China.
Jiali Yang2 General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Juan Chen2 General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Juan Shi2 General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Xiaoming Liu1 College of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.ORCID 0000-0002-3902-9105
Ningxia Medical University · CNNingxia University · CNThe Fourth People's Hospital of Ningxia Hui Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains one of the most common cancer-related deaths worldwide. The cigarette smoking is a risk factor for lung cancer development. Interestingly, the cystic fibrosis transmembrane conductance regulator encoded by CFTR gene, an ATP-binding cassette transporter-class ion channel that conducts chloride and bicarbonate anions across membrane of epithelial cells, has recently been suggested to play a role in the development and progression of many types of cancer. It has been well-documented that mutations of CFTR gene are the cause of cystic fibrosis, the most common fatal hereditary lung disease in Caucasian population; the function of cystic fibrosis transmembrane conductance regulator in the development of lung cancer however has not yet been established. In the present study, we aimed to interrogate the impact of cystic fibrosis transmembrane conductance regulator on the nicotine-promoted progressive potency in lung adenocarcinoma cells by assessing capacities of cystic fibrosis transmembrane conductance regulator to cell migration, invasion, and clonogenicity and the expression of markers of cell proliferation and lung stem cell-related transcription factors in lung adenocarcinoma A549 cells. The exposure of nicotine exhibited an ability to enhance progressive properties of adenocarcinoma cells including A549 cells, HCC827 cells, and PC-9 cells, alone with an inhibition of cystic fibrosis transmembrane conductance regulator protein expression. Remarkably, an overexpression of cystic fibrosis transmembrane conductance regulator significantly inhibited the progressive potency of A549 cells, including capacity of cell migration and invasion and clonogenicity, along with a decreased expression of cell proliferative markers Ki67, p63, and proliferating cell nuclear antigen, and cancer stem cell marker CD133, stem cell pluripotency-related transcription factors octamer-binding transcription factor ¾, and sex-determining region Y-box 2, regardless of the presence of nicotine. In contrast, opposite effects were observed in A549 cells that the cystic fibrosis transmembrane conductance regulator was knockdown by short hairpin RNA to cystic fibrosis transmembrane conductance regulator. This study thus suggests that cystic fibrosis transmembrane conductance regulator may play a tumor suppressor role in lung cancer cells, which may be a novel therapeutic target warranted for further investigation.

Indexed as

A549 CellsAC133 AntigenAdenocarcinoma of LungCell Line, TumorCell MembraneCell MovementCell ProliferationCystic Fibrosis Transmembrane Conductance RegulatorEpithelial CellsHumansLungLung NeoplasmsMutationNeoplastic Stem CellsNicotineSignal TransductionAC133 AntigenCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorNicotinecancer cell progressioncancer stem cellscell proliferationcystic fibrosis transmembrane conductance regulatorlung cancernicotine

Identifiers

PMID30384810
PMCPMC6259057
OpenAlexW2899345818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.